Mirikizumab

What it is used for

OMVOH is indicated for the treatment of:

• moderately to severely active ulcerative colitis in adults.
• moderately to severely active Crohn's disease in adults.

Side effects, and when to stop

The following topics are also discussed in detail in the Warnings and Precautions section:

• Hypersensitivity Reactions
• Infections
• Tuberculosis
• Hepatotoxicity

Who should not take it

OMVOH is contraindicated in patients with a history of serious hypersensitivity reaction to mirikizumab-mrkz or any of the excipients.

Storing it

Storage and Handling

• Store refrigerated at 2°C to 8°C (36°F to 46°F).
• Do not freeze. Do not use OMVOH if it has been frozen.
• Do not shake.
• Keep OMVOH in the original carton to protect from light until the time of use.
• OMVOH is sterile and preservative-free. Discard any unused portion.
• If needed, the prefilled pen or prefilled syringe may be stored at room temperature up to 30°C (86°F) for up to 2 weeks in the original carton to protect from light. Once OMVOH has been stored at room temperature, do not return to the refrigerator. If these conditions are exceeded, OMVOH must be discarded.
• The vial, prefilled pen, and prefilled syringe are not made with dry natural rubber latex.